The anti-inflammatory effect of cyclooxygenase inhibitors in fibroblast-like synoviocytes from the human temporomandibular joint results from the suppression of PGE2 production

Synergy between adiponectin and interleukin-1β on the expression of interleukin-6, interleukin-8, and cyclooxygenase-2 in fibroblast-like synoviocytes

(2012) Yeon-Ah Lee et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Celecoxib

(2011) Paul L. McCormack   DRUGS

Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis

(2011) Manon C Zweers et al.   ARTHRITIS RESEARCH & THERAPY

Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis

(2010) Benoit Le Goff et al.   JOINT BONE SPINE

Prostaglandin E2and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis

(2009) Xin Li et al.   ARTHRITIS AND RHEUMATISM

Interleukin-6 as a key player in systemic inflammation and joint destruction

(2009) J.E. Fonseca et al.   AUTOIMMUNITY REVIEWS

Prostaglandin E2 Differentially Modulates Proinflammatory/Prodestructive Effects of TNF-  on Synovial Fibroblasts via Specific E Prostanoid Receptors/cAMP

(2009) E. Kunisch et al.   JOURNAL OF IMMUNOLOGY

Expression of cyclooxygenase-1 and -2 in IL-1β-induced synovitis of the temporomandibular joint

(2009) K. Satoh et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Selective cyclooxygenase-2 inhibitor prevents reduction of trabecular bone mass in collagen-induced arthritic mice in association with suppression of RANKL/OPG ratio and IL-6 mRNA expression in synovial tissues but not in bone marrow cells

(2008) Tomonori Taketa et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Effects of nonsteroidal anti-inflammatory drugs on the expression of urokinase plasminogen activator and inhibitor and gelatinases in the early osteoarthritic knee of humans

(2007) Shun-Fa Yang et al.   CLINICAL BIOCHEMISTRY